• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估沙特阿拉伯多发性硬化症患者中与抑郁和焦虑相关的因素。

Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia.

机构信息

King Fahad Medical City, Riyadh, Saudi Arabia.

College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

BMC Neurol. 2022 Mar 25;22(1):120. doi: 10.1186/s12883-022-02632-2.

DOI:10.1186/s12883-022-02632-2
PMID:35337277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948449/
Abstract

BACKGROUND

Multiple sclerosis (MS) is an inflammatory chronic disease that is characterized by an increased prevalence of adverse mental health outcomes in patients with MS (pwMS). The main aim of this study is to investigate the factors of depression and anxiety in pwMS in the Kingdom of Saudi Arabia (KSA).

MATERIALS AND METHODS

This is a cross-sectional study conducted in KSA during the period from March to June 2020. Participants were recruited from the Neuroimmunology clinics in King Fahad Medical City (KFMC) and King Saud University medical city (KSUMC)in Riyadh City, KSA. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety. Fatigue Severity Scale (FSS) was used to measure fatigue in pwMS. A simple random sampling technique was utilized to select participants and the data were analyzed using SPSS v.24.0.

RESULTS

A total of 529 participants participated in this study with a response rate of 53.1%. The prevalences of anxiety and depression were 35.3% and 19.7%, respectively. The findings also revealed that depression was more likely to be significantly affected by being male, low education, unemployment, physical inactivity, and fatigue but the anxiety was significantly affected by region, unemployment, short duration since last MS relapse, physical inactivity, and fatigue.

CONCLUSION

Anxiety and depression are not uncommon in pwMS. Given their impact on the lives of affected patients, early detection and management of these symptoms and their associated factors are crucial.

摘要

背景

多发性硬化症(MS)是一种炎症性慢性疾病,其特点是 MS 患者(pwMS)的心理健康不良结局发生率增加。本研究的主要目的是调查沙特阿拉伯王国(KSA)pwMS 中抑郁和焦虑的相关因素。

材料与方法

这是一项在 2020 年 3 月至 6 月期间在 KSA 进行的横断面研究。参与者从 KFMC 和 KSUMC 的神经免疫科招募。采用医院焦虑抑郁量表(HADS)评估抑郁和焦虑,采用疲劳严重程度量表(FSS)评估 pwMS 的疲劳。采用简单随机抽样技术选择参与者,使用 SPSS v.24.0 对数据进行分析。

结果

共有 529 名参与者参与了本研究,应答率为 53.1%。焦虑和抑郁的患病率分别为 35.3%和 19.7%。研究结果还表明,抑郁更可能受到男性、低教育程度、失业、缺乏身体活动和疲劳的显著影响,而焦虑则显著受到地区、失业、上次 MS 复发后时间较短、缺乏身体活动和疲劳的影响。

结论

焦虑和抑郁在 pwMS 中并不少见。鉴于这些症状对受影响患者生活的影响,早期发现和管理这些症状及其相关因素至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d274/8953046/48dd2535f117/12883_2022_2632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d274/8953046/48dd2535f117/12883_2022_2632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d274/8953046/48dd2535f117/12883_2022_2632_Fig1_HTML.jpg

相似文献

1
Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia.评估沙特阿拉伯多发性硬化症患者中与抑郁和焦虑相关的因素。
BMC Neurol. 2022 Mar 25;22(1):120. doi: 10.1186/s12883-022-02632-2.
2
Fatigue, Depression, and Anxiety Among Ambulating Multiple Sclerosis Patients.多发性硬化症患者行走时的疲劳、抑郁和焦虑。
Front Immunol. 2022 Mar 29;13:844461. doi: 10.3389/fimmu.2022.844461. eCollection 2022.
3
Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia.沙特阿拉伯利雅得市成年多发性硬化症患者的抑郁和焦虑患病率。
Neurosciences (Riyadh). 2022 Apr;27(2):71-78. doi: 10.17712/nsj.2022.2.20210101.
4
The Role of Exercise on Fatigue Among Patients With Multiple Sclerosis in the King Fahad Hospital, Madinah, Saudi Arabia: An Analytical Cross-Sectional Study.沙特阿拉伯麦地那法赫德国王医院多发性硬化症患者运动对疲劳的影响:一项分析性横断面研究
Cureus. 2023 Jul 18;15(7):e42061. doi: 10.7759/cureus.42061. eCollection 2023 Jul.
5
The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.COVID-19 大流行对沙特阿拉伯多发性硬化症患者的心理影响。
Neurosciences (Riyadh). 2023 Apr;28(2):108-115. doi: 10.17712/nsj.2023.2.20110104.
6
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.多发性硬化症中焦虑、抑郁和疲劳随时间的流行率和并存性。
Mult Scler. 2013 Feb;19(2):217-24. doi: 10.1177/1352458512450351. Epub 2012 Jun 22.
7
Reliability and validity of the Hospital Anxiety and Depression Scale in an emergency department in Saudi Arabia: a cross-sectional observational study.沙特阿拉伯某急诊科医院焦虑抑郁量表的信度和效度:一项横断面观察性研究
BMC Emerg Med. 2015 Oct 12;15:28. doi: 10.1186/s12873-015-0051-4.
8
Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia.影响沙特阿拉伯多发性硬化症患者生活质量的因素。
Disabil Rehabil. 2022 Aug;44(17):4775-4783. doi: 10.1080/09638288.2021.1919929. Epub 2021 May 9.
9
Factors associated with the prevalence of depression and anxiety among parents of children with neurodevelopmental disorders in Saudi Arabia.沙特阿拉伯神经发育障碍儿童父母中抑郁和焦虑患病率的相关因素。
BMC Public Health. 2023 Nov 23;23(1):2320. doi: 10.1186/s12889-023-17228-9.
10
Self-reported depression and anxiety rates among females with cutaneous leishmaniasis in Hubuna, Saudi Arabia.沙特阿拉伯胡布纳女性皮肤利什曼病患者自述的抑郁和焦虑发生率。
PeerJ. 2023 Jun 20;11:e15582. doi: 10.7717/peerj.15582. eCollection 2023.

引用本文的文献

1
Mental Health Consequences of COVID-19 Vaccine Side Effects: Findings From a Cross-Sectional Analysis.新冠疫苗副作用的心理健康后果:一项横断面分析的结果
Health Sci Rep. 2025 Jun 30;8(7):e70998. doi: 10.1002/hsr2.70998. eCollection 2025 Jul.
2
Assessing Social Determinants of Health Among Patients With Depression at Primary Healthcare Centers in Riyadh City.评估利雅得市初级医疗中心抑郁症患者的健康社会决定因素。
Cureus. 2023 Nov 15;15(11):e48854. doi: 10.7759/cureus.48854. eCollection 2023 Nov.

本文引用的文献

1
Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.2019冠状病毒病大流行对多发性硬化症患者的心理影响:一项快速系统评价
Mult Scler Relat Disord. 2022 Mar;59:103562. doi: 10.1016/j.msard.2022.103562. Epub 2022 Jan 25.
2
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.在一个大型多发性硬化症门诊患者群体中,肠功能障碍的流行情况和预测因素:一项意大利多中心研究。
J Neurol. 2022 Mar;269(3):1610-1617. doi: 10.1007/s00415-021-10737-w. Epub 2021 Aug 4.
3
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.
多发性硬化症管理的综合方法:应对隐匿症状——一项叙述性综述
Neurol Ther. 2021 Jun;10(1):75-98. doi: 10.1007/s40120-021-00239-2. Epub 2021 Apr 20.
4
Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis.多发性硬化症中性功能障碍的诱发因素。
Front Neurol. 2021 Feb 9;12:618370. doi: 10.3389/fneur.2021.618370. eCollection 2021.
5
Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients.波兰多发性硬化症患者队列中疲劳与身体活动的关系。
Medicina (Kaunas). 2020 Dec 21;56(12):726. doi: 10.3390/medicina56120726.
6
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.全球多发性硬化症患病率上升:第三版多发性硬化症图谱的见解。
Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11.
7
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience.COVID-19 大流行期间封锁放松后很快重返工作岗位的复发性缓解型多发性硬化症意大利患者的心理健康状况:单中心经验。
Mult Scler Relat Disord. 2020 Nov;46:102561. doi: 10.1016/j.msard.2020.102561. Epub 2020 Oct 3.
8
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients.多发性硬化症患者下尿路症状的药物治疗管理。
Expert Opin Pharmacother. 2020 Aug;21(12):1449-1454. doi: 10.1080/14656566.2020.1767068. Epub 2020 May 26.
9
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study.伊朗克尔曼沙阿多发性硬化症患者的焦虑、抑郁和压力患病率:一项横断面研究。
BMC Psychiatry. 2020 Apr 15;20(1):166. doi: 10.1186/s12888-020-02579-z.
10
Multiple Sclerosis Patients in Saudi Arabia: Prevalence of Depression and its Extent of Severity.沙特阿拉伯的多发性硬化症患者:抑郁症的患病率及其严重程度
Cureus. 2020 Feb 15;12(2):e7005. doi: 10.7759/cureus.7005.